AMERICAN ASSOCIATION FOR CANCER RESEARCH 17
that the economic burden will rise sharply too ( 21). This
underscores the urgent need for more research so that
we can accelerate the pace of progress against cancer.
Recent advances, some of which are highlighted in this
report, were made as a direct result of the cumulative
efforts of researchers from across the spectrum of research
disciplines. Much of their work, as well as the federal
regulatory agency that assures the safety and efficacy of
medical devices and therapeutic advances—the FDA—is
supported by funds from the federal government. While
the consecutive $2 billion increases for the NIH budget
in fiscal year (FY) 2016 and FY 2017 were a welcome
boost, to maintain a vibrant cancer research enterprise
it is imperative that Congress provide sustained, robust,
and predictable increases in investments in the federal
agencies that are vital for fueling progress against cancer,
in particular the NIH, NCI, and FDA, in the years ahead.
access to and use of health care;
exposure to environmental cancer
clinical trial participation;
Why Do Cancer Health Disparities Exist?
Complex and interrelated factors contribute to U.S. cancer health disparities.
The factors may include, but are not limited to, differences and/or inequalities in:
Data from ( 21)